Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Kishida

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 14, 2011
[Etiology of atherosclerosis--special reference to humoral and neurogenic factors]Ken Kishida, Tohru Funahashi
Current Diabetes Reviews|February 8, 2012
Clinical importance of assessment of type 2 diabetes mellitus with visceral obesity. A Japanese perspectiveKen Kishida, Tohru Funahashi, Iichiro Shimomura
Nutrition & Metabolism|August 18, 2011
Clinical significance of visceral fat reduction through health education in preventing atherosclerotic cardiovascular disease - Lesson from the Amagasaki Visceral Fat Study: A Japanese perspectiveKen Kishida, Tohru Funahashi, Iichiro Shimomura
Endocrine, Metabolic & Immune Disorders Drug Targets|January 13, 2012
Molecular mechanisms of diabetes and atherosclerosis: role of adiponectinKen Kishida, Tohru Funahashi, Iichiro Shimomura
Cardiovascular & Hematological Disorders Drug Targets|April 25, 2012
Importance of assessing the effect of statins on the function of high- density lipoproteins on coronary plaqueKen Kishida, Tohru Funahashi, Iichiro Shimomura
Best Practice & Research. Clinical Endocrinology & Metabolism|January 15, 2014
Adiponectin as a routine clinical biomarkerKen Kishida, Tohru Funahashi, Iichiro Shimomura
Diabetes Research and Clinical Practice|December 14, 2011
Three-month treatment with pioglitazone reduces circulating levels of S100A8/A9 (MRP8/14) complex, a biomarker of inflammation, without changes in body mass index, in type 2 diabetics with abdominal obesityHideaki Nakatsuji, Ken Kishida, Tohru Funahashi, et al.
Annals of Medicine|May 27, 2011
Visceral adiposity as a target for the management of the metabolic syndromeKen Kishida, Tohru Funahashi, Yuji Matsuzawa, et al.
Endocrine Journal|October 15, 2011
Characteristics of sleep-disordered breathing in Japanese patients with acromegalySusumu Kashine, Ken Kishida, Tohru Funahashi, et al.
Diabetology & Metabolic Syndrome|May 4, 2012
Sleep-wake cycle irregularities in type 2 diabeticsTomoko Nakanishi-Minami, Ken Kishida, Tohru Funahashi, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 14, 2011
[Etiology of atherosclerosis--special reference to humoral and neurogenic factors]Ken Kishida, Tohru Funahashi
Current Diabetes Reviews|February 8, 2012
Clinical importance of assessment of type 2 diabetes mellitus with visceral obesity. A Japanese perspectiveKen Kishida, Tohru Funahashi, Iichiro Shimomura
Nutrition & Metabolism|August 18, 2011
Clinical significance of visceral fat reduction through health education in preventing atherosclerotic cardiovascular disease - Lesson from the Amagasaki Visceral Fat Study: A Japanese perspectiveKen Kishida, Tohru Funahashi, Iichiro Shimomura
Endocrine, Metabolic & Immune Disorders Drug Targets|January 13, 2012
Molecular mechanisms of diabetes and atherosclerosis: role of adiponectinKen Kishida, Tohru Funahashi, Iichiro Shimomura
Cardiovascular & Hematological Disorders Drug Targets|April 25, 2012
Importance of assessing the effect of statins on the function of high- density lipoproteins on coronary plaqueKen Kishida, Tohru Funahashi, Iichiro Shimomura
Best Practice & Research. Clinical Endocrinology & Metabolism|January 15, 2014
Adiponectin as a routine clinical biomarkerKen Kishida, Tohru Funahashi, Iichiro Shimomura
Diabetes Research and Clinical Practice|December 14, 2011
Three-month treatment with pioglitazone reduces circulating levels of S100A8/A9 (MRP8/14) complex, a biomarker of inflammation, without changes in body mass index, in type 2 diabetics with abdominal obesityHideaki Nakatsuji, Ken Kishida, Tohru Funahashi, et al.
Annals of Medicine|May 27, 2011
Visceral adiposity as a target for the management of the metabolic syndromeKen Kishida, Tohru Funahashi, Yuji Matsuzawa, et al.
Endocrine Journal|October 15, 2011
Characteristics of sleep-disordered breathing in Japanese patients with acromegalySusumu Kashine, Ken Kishida, Tohru Funahashi, et al.
Diabetology & Metabolic Syndrome|May 4, 2012
Sleep-wake cycle irregularities in type 2 diabeticsTomoko Nakanishi-Minami, Ken Kishida, Tohru Funahashi, et al.
Pageof 8